Agios Pharmaceuticals, Inc. (AGIO): Shares Outstanding

Annual figures by period end, from SEC filings.

58.45M
As of 2025-12-31
59.60M
As of 2026-06-30
+2.0%
3-year compound annual growth
-3.3%
5-year compound annual growth
+4.5%
10-year compound annual growth
69.29M2012-12-31: 3.62M2013-12-31: 31.20M2014-12-31: 37.10M2015-12-31: 37.70M2016-12-31: 42.22M2017-12-31: 48.83M2018-12-31: 58.22M2019-12-31: 68.40M2020-12-31: 69.29M2021-12-31: 54.33M2022-12-31: 55.04M2023-12-31: 55.95M2024-12-31: 57.16M2025-12-31: 58.45M58.45M
2012-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3158.45M+2.3%2026-02-12, Balance as of period end
2024-12-3157.16M+2.2%2026-02-12, Balance as of period end
2023-12-3155.95M+1.6%2025-02-13, Balance as of period end
2022-12-3155.04M+1.3%2024-02-15, Balance as of period end
2021-12-3154.33M-21.6%2023-02-23, Balance as of period end
2020-12-3169.29M+1.3%2022-02-24, Balance as of period end
2019-12-3168.40M+17.5%2021-02-25, Balance as of period end
2018-12-3158.22M+19.2%2020-02-19, Balance as of period end
2017-12-3148.83M+15.6%2019-02-14, Balance as of period end
2016-12-3142.22M+12.0%2018-02-14, Balance as of period end
2015-12-3137.70M+1.6%2017-02-16, Balance as of period end
2014-12-3137.10M+18.9%2016-02-26, Balance as of period end
2013-12-3131.20M+762.9%2015-02-24, Balance as of period end
2012-12-313.62Mn/a2014-03-18, Balance as of period end